Article
A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk.
Gut - 1 Jan 2014
He Meian, Wu Chen, Xu Jianfeng, Guo Huan, Yang Handong, Zhang Xiaomin, Sun Jielin, Yu Dianke, Zhou Li, Peng Tao, He Yunfeng, Gao Yong, Yuan Jing, Deng Qifei, Dai Xiayun, Tan Aihua, Feng Yingying, Zhang Haiying, Min Xinwen, Yang Xiaobo, Zhu Jiang, Zhai Kan, Chang Jiang, Qin Xue, Tan Wen, Hu Yanling, Lang Mingjian, Tao Sha, Li Yuanfeng, Li Yi, Feng Junjie, Li Dongfeng, Kim Seong-Tae, Zhang Shijun, Zhang Hongxing, Zheng S Lilly, Gui Lixuan, Wang Youjie, Wei Sheng, Wang Feng, Fang Weimin, Liang Yuan, Zhai Yun, Chen Weihong, Miao Xiaoping, Zhou Gangqiao, Hu Frank B, Lin Dongxin, Mo Zengnan, Wu Tangchun
Abstract excerpt
OBJECTIVE: Tumour biomarkers are used as indicators for cancer screening and as predictors for therapeutic responses and prognoses in cancer patients. We aimed to identify genetic loci that influence concentrations of cancer antigen 19-9 (CA19-9), carcinoembryonic antigen (CEA) and α fetoprotein (AFP), and investigated the associations between the significant single nucleotide polymorphisms (SNPs) with risks of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
